Allergies are increasing, and despite deeper insights into the immunologic basis of these diseases, preventive measures are not yet efficient. As the induction of allergic diseases is often triggered in early childhood, perinatal or prenatal preventive strategies would be beneficial. We investigated the transfer of inhalant and nutritive allergens across the human placenta. For this purpose, the maternal side of a placental cotyledon was perfused in vitro with an allergen-containing medium, and a specific ELISA was used to detect the allergens on the fetal side. Both allergens evaluated, birch pollen major allergen Bet v1 and the milk allergen beta-lactoglobulin, could be shown to cross the placenta. The nutritive allergen beta-lactoglobulin was not only transferred across the placenta in all eight experiments, but was also detectable within the first minutes of perfusion. The peak allergen concentration on the fetal side could be increased by addition of human immunoglobulin. For the inhalant allergen Bet v1, transfer was observed in two of 10 placental experiments, and only if human immunoglobulin was added. A pulsatility wave with a frequency of 30 -35 min suggested an active transfer mechanism. We conclude that allergens are actively and selectively transferred across the placenta. Therefore, controlled maternal allergen exposure might offer new ways to induce tolerance to specific allergens in the fetus. There is increasing evidence that the prevalence of allergic diseases is currently rising at an unprecedented rate (1-3). It is also becoming clear that this rise is largely restricted to developed countries, a phenomenon that is widely believed to be linked to a western lifestyle (4). Eliciting agents, preferentially environmental allergens, are predominantly found in indoor environments. Recently, concern has been raised as to any priming effects of exposure to environmental influences even before birth; that is, through the placenta.Allergen-specific T cell proliferation in cord blood cells has been demonstrated by many groups and for many different allergens (5-15). Inhalant and nutritive allergens in the form of crude extracts [birch pollen (5, 7), house dust mite (8 -10, 15), timothy grass pollen (5, 7), cat fur (5, 7), BLG (5, 7, 13, 16), alpha-casein (13), beta-casein (13), kappa-casein (13), BSA (5-7, 13), and ovalbumin (5, 7, 11, 15, 16)] and in the form of recombinant allergens [Lol p1 (9), Der p1 (9), Bet v1 (14), and Phl p1 (14)] has been studied. A line of evidence now supports the hypothesis that fetal T cells are exposed during gestation to maternally derived allergens. These allergens may be ingested or inhaled by the mother (14). The time at which maternofetal allergen exposure takes place in the course of a pregnancy is less clear. The current knowledge suggests early times during gestation, presumably around wk 20 of gestation (5, 14), Szépfalusi et al. unpublished experiments).The occurrence of prenatal T cell priming and its possible impact on later allergic status has been the subject...